Microbial susceptibility, virulence factors, and plasmid profiles of uropathogenic Escherichia coli strains isolated from children in Jahrom, Iran

Archives of Iranian Medicine

Volumn 15, Issue 5, 2012, Pages 312-316

  Farshad, Shohreh ^a   Ranjbar, Reza ^b   Japoni, Aziz ^a   Hosseini, Marziyeh ^a   Anvarinejad, Mojtaba ^a   Mohammadzadegan, Reza ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

E. coli; Plasmid; UTI; Virulence genes

Indexed keywords

AMIKACIN; AMPICILLIN; CEFIXIME; CIPROFLOXACIN; COTRIMOXAZOLE; CYTOTOXIC NECROTIZING FACTOR 1; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NITROFURANTOIN; TETRACYCLINE; VIRULENCE FACTOR; ANTIINFECTIVE AGENT;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CHILD; COMMUNICABLE DISEASE; CONCENTRATION RESPONSE; CYTOTOXIC NECROTIZING FACTOR 1 GENE; DRUG EFFECT; EPIDEMIC; FEMALE; GENETIC ANALYSIS; GENETIC SIMILARITY; GENOTYPE; HLY GENE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; NONHUMAN; PAP GENE; PLASMID; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SFA GENE; URINALYSIS; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; CROSS INFECTION; ESCHERICHIA COLI INFECTION; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE;

ANTI-BACTERIAL AGENTS; CHILD; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI INFECTIONS; HUMANS; IRAN; MICROBIAL SENSITIVITY TESTS; PLASMIDS; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE FACTORS;

EID: 84864055296     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Umolu Pdia, Okoli EN, Izomoh IM. Antimicrobial susceptibility and plasmid profiles of Escherichia coli isolates obtained from different human clinical specimens in Lagos - Nigeria. J Am Sci. 2006; 2: 70-76.
2. Vila J, Simon K, Ruiz J, Horcajada JP, Velasco M, Barranco M, et al. Are quinolone-resistant uropathogenic Escherichia coli less virulent? J Infect Dis. 2002; 186: 1039-1042.
3. Svanborg C, Godaly G. Bacterial virulence in urinary tract infection. Infect Dis Clin North Am. 1997; 11: 513-529.
4. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev. 1991; 4: 80-128.
5. Hacker J, Blum-Oehler G, Mühldorfer I, Tschäpe H. Pathogenicity islands of virulent bacteria: Structure, function and impact on microbial evolution. Mol Microbiol. 1997; 23: 1089-1097.
6. Farshad S, Emamghoraishi F, Japoni A. Association of virulent genes hly, sfa, cnf-1 and pap with antibiotic sensitivity in Escherichia coli strains isolated from children with community-acquired UTI. Iran Red Cresc Med J. 2010; 12: 30-34.
7. Hassan SH. Sensitivity of salmonella and shigella to antibiotics and chemotherapeutic agents in Sudan. J Trop Med Hyg. 1985; 88: 243-248.
8. Horcajada JP, Soto S, Gajewki A, Smithson A, Jiménez de Anta MT, Mensa J, et al. Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J Clin Microbiol. 2005; 43: 2962-2964.
9. Farmer JJ. Enterobacteriaceae: Introduction and identification. In: Murray PR, Baron EJ, Phaler MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. Washington: ASM Press; 1999: 438.
10. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Eighth informational supplement Villanova, PA, 2000. Approved standard M2 A7.
11. Arisoy M, Aysev D, Ekim M, Özel D, Kose SK, Özsoy ED, et al. Detection of virulence factors of Escherichia coli from children by multiplex polymerase chain reaction. Inter J Clini Pract. 2006; 60: 170-173.
12. Yamamoto S, Terai A, Yuri K, Kurazono H, Takeda Y, Yoshida O, et al. Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS Immunol Med Microbiol. 1995; 12: 85-90.
13. Birnboim H, Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 1979; 7: 1513-1523.
14. Soto S, Jimenez de Anta M, Vila J. Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOS-dependent or-independent pathways, respectively. Antimicrob Agents Chemother. 2006; 50: 649-653.
15. Mehr SS, Powell CV, Curtis N. Cephalosporin resistant urinary tract infection in young children. J Paedi Child Health. 2004; 40: 48-52.
16. Mathai E, Grape M, Kronvall G. Integrons and multidrug resistance among Escherichia coli causing community acquired urinary tract infection in southern India. APMIS. 2004; 112: 159-164.
17. Rijavec M, Starcic Ergivec M, Ambrozic Augustin J, Reissbrodt R, Fruth A, Krizan-Hergouth V, et al. High prevalence of multidrug resistance and random distribution of mobile genetic elements among uropathogenic Escherichia coli (UPEC) of the four major phylogenetic groups. Curr Microbiol. 2006; 53: 158-162.
18. Japoni A, Gudarzi M, Farshad SH, Basiri E, Ziyaeyan M, Alborzi A, et al. Assay for integrons and pattern of antibiotic resistance in clinical Escherichia coli strains by PCR-RFLP in Southern Iran. Jpn J Infect Dis. 2008; 61: 85-88.
19. Adwan K, Abu-hasan N, Adwan G, Jarrar N, Abu-shanab B, Al-masri M. Molecular epidemiology of antibiotic-resistant Escherichia coli isolated from hospitalized patient with urinary tract infection in Northen Palestine. Pol J Microbiol. 2004; 53: 23-26.
20. Tariq N, Jaffery T, Ayub R, Alam AY, Javid MH, Shafique S. Frequency and antimicrobial susceptibility of aerobic bacterial vaginal isolates. JCPSP. 2006. 16: 196-199.
21. Gulsun S, Oguzoglu N, Inan A, Ceran N. The virulence factors and antibiotic sensitivities of Escherichia coli isolated from recurrent urinary tract infections. Saudi Med J. 2005; 26: 1755-1758.
22. Shao HF, Wang WP, Zhang XW, Li ZD (2004). Distribution and resistance trends of pathogens from urinary tract infections and impact on management. Internal. J. Antimicrob. Agents. 23: 2-5.
23. Kawamori, F, Hiroi M, Harada T, Ohata K, Sugiyama K, Masuda T, et al. Molecular typing of Japanese Escherichia coli 0157:H7 isolates from clinical specimens by multilocus variable number tandem repeat analysis and PFGE. J Med Microbiol. 2008; 57: 58-63.
24. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis. 2001; 33: 757-762.
25. Linder JA, Huang ES, Steinman MA, Gonzales R, Stafford RS. Fluoroquinolone prescribing in the United States: 1995 to 2002. Am J Med. 2005; 118: 259-268.
26. Wolff O, Maclennan C. Evidence behind the WHO guidelines hospital care for children: What is the appropriate empiric antibiotic therapy in uncomplicated urinary tract infection in children in developing countries? J Trop Ped. 2007; 53: 150-152.
27. Woo-joo K, Hee-Lin J, Hyun-Jin P, Min-Ja K, Seung-Chull P. Application of ribotyping for molecular epidemiology study of Escherichia coli isolated from patients with urinary tract infection. Kor J Infect Dis. 1995; 27: 505-517.
28. Fluit AC, Janes ME. Antimicrobial resistance among UTI isolates in Europe. Antonie van Leeuwenhoek. 2001; 77: 147-152.
29. Malkawi HI, Youssef MT. Antibiotic susceptibility testing and plasmid profile of Escherichia coli isolated from diarrhoeal patients. J Trop Ped. 1998; 44: 128-132.
30. Tsen HY, Chi WR. Plasmid profile analysis for enterotoxigenic Escherichia coli and detection for heat stable enterotoxin I (ST1) gene by polymerase chain reaction. J Food Drug Analysis. 1996; 4: 215-222.
31. Danbara H, Komase K, Yasuyuki Kirii K, Shinohara M, Arita H, Makino S, et al. Analysis of the plasmids of Escherichia coli 0148:H28 from travelers with diarrhoea. Microbial Patholog. 1987; 3: 269-278.
32. Al-Bahry Saif N, Al-Mashani Basma M, Elshafie Abdulkadir E, Pathare N, Al-Harthy Asila H. Plasmid profile of antibiotic resistant Escherichia coli isolated from chicken intestines. J Ala Acad Sci 2006; 77: 152.
33. Garcia M, Le Bouguénec C. Role of adhesion in pathogenicity of human uropathogenic and diarrhoeogenic Escherichia coli. Bulletin de l'Institute Pasteur. 1996; 94: 201-236.
34. Usein C, Damian M, Tatu-Chitoiu D, Capusa C, Fagaras R, Tudorache D, et al. Prevalence of virulence genes in Escherichia coli strains isolated from Romanian adult urinary tract infection cases. J Cell Mol Medi. 2001; 5: 303-310.
35. Wullt B. The role of P fimbriae for Escherichia coli establishment and mucosal inÀammation in the human urinary tract. Inter J Antimicrob Agents. 2003; 21: 605-621.